[骨髓增殖性瘤中的克隆进化]
1Division of Cancer Evolution, National Cancer Center Research Institute.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|September 4, 2024
概括
最近的进展揭示了费城染色体阴性骨髓增殖性新生瘤 (MPNs) 中的驱动突变. 这些突变,包括表观遗传调节者,可以在生命早期出现,并影响疾病的进展.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 测序技术已经推进了对费城染色体阴性骨髓增殖性新生瘤 (MPNs) 驱动基因突变的理解.
- 除了JAK2,MPL和CALR突变之外,表观遗传调节剂和RNA拼接因子都与MPN病变产生有关.
- 克隆性造血,即带有驱动突变的造血细胞的扩张,在健康个体中观察到,特别是老年人.
研究的目的:
- 审查最近关于MPNs克隆进化的发现.
- 阐明驱动突变在MPN发展和进展中的作用.
主要方法:
- 关于MPNs,驱动突变和克隆进化的最新科学文献的综述.
- 测序数据和与MPN病变发生相关的遗传研究的分析.
主要成果:
- 除了主要的MPN驱动因素之外,对表观遗传调节剂和RNA剪接因子的体质突变的鉴定.
- 这些突变与转变为髓纤维化和急性髓性白血病的关联.
- 证据表明,MPN患者的初始驱动突变,如JAK2和DNMT3A,可以在产前或儿童时期获得.
结论:
- 驱动突变在MPNs的克隆进化中发挥着关键作用.
- 了解驱动突变的时间和频谱对于理解MPN病原和开发向疗法至关重要.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cells of the Adaptive Immune Response
972
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972
Disorders of Leukocytes
914
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
914
Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K


